Melanoma 92 " . Epidemiological study of uveal melanomainFrance, p.520528, 1995. ,
Melanomas of the eye and other noncutaneous sites : epidemiologicaspects, p.489491, 1976. ,
Heliumionsversusiodine125brachytherapyinthe managementofuvealmelanoma.Aprospective,randomized,dynamicallybalancedtrial, p.15471554, 1993. ,
Treatmentofneovascularglaucomaafter proton therapy for uveal melanomas with ranibizumab injection : preliminary results, p.5760, 2012. ,
Maximumtolerateddoseofahumanizer antivascular endothelial growth factor antibody fragment for treating neovascular age ? relatedmaculardegeneration, Ophtalmology, vol.112, p.10481053, 2005. ,
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group Pegaptanib sodiumforneovascularagerelatedmaculardegeneration:twoyearsafetyresultsofthetwo prospective,multicenter,controlledclinicaltrials, p.9921001, 2006. ,
ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular agerelated macular degeneration, p.143244, 2006. ,
Twoyear outcomes of the ranibizumab for edema of the macula in diabetes (READ2) study, Ophthalmology, vol.117, p.214651, 2010. ,
Retinalveinocclusion: antiVEGF treatments, J Fr Ophtalmol, vol.32, issue.9, p.67986, 2009. ,
Antiangiogenic therapy elicits malignant progression of tumors to increasedlocalinvasionanddistantmetastasis, p.220231, 2009. ,
Proton Beam Radiotherapy for Uveal Melanomas at Nice Teaching Hospital: 16 Years' Experience, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.1, p.98103, 2010. ,
DOI : 10.1016/j.ijrobp.2009.07.1688
Clinical factors in the identification of small choroidalmelanoma, CanJOphthalmol, vol.39, p.351357, 2004. ,
Uveal Melanoma: Trends in Incidence, Treatment, and Survival, Ophthalmology, vol.118, issue.9, p.18811885, 2011. ,
DOI : 10.1016/j.ophtha.2011.01.040
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, Ophthalmology, vol.109, issue.12, p.2197, 2002. ,
DOI : 10.1016/S0161-6420(02)01277-0
Radiotherapy for large posterior uveal melanoma (>OR=8mmthick)in354consecutivepatients, Ophtalmology, vol.109, p.18381849, 2002. ,
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma , II : characteristics of patients enrolled and not enrolled, COMSreportno17.ArchOphtalmol, vol.119, issue.7, p.951965, 2001. ,
Uveal malignant melanoma : management options brachytherapy, ClinicalOphtalmicOncology, p.241247, 2007. ,
DOI : 10.1016/b978-1-4160-3167-3.50046-2
Visual Acuity after Ruthenium(106) brachytherapy of choroidal melanomas, IntJRadiatOncolBiolPhys, vol.63, issue.2, p.392400, 2005. ,
Eccentric ruthenium plaque radiotherapy of posterior choroidalmelanoma, GraefesArchclinExpOphtalmol, vol.250, issue.10, p.15331540, 2012. ,
Proton beam radiotherapy of choroidal melanoma : the LiverpoolClatterbridgeexperience, IntJRadiatOncolBiolPhys, vol.62, issue.5, p.14051411, 2005. ,
Chargedparticleradiationtherapyforuvealmelanoma:asystematicreview andmetaanalysis.IntJRadiatOncolBiolPhys, 2012. ,
Evidencebased estimates of outcome in patients irradiatedforintraocularmelanoma, ArchOphthalmol, vol.120, issue.12, p.16551671, 2002. ,
Treatment of amelanotic choroidal melanoma with photodynamictherapy, Retina, vol.201232, issue.7, p.13561362 ,
Thecomparisonofrutheniumbrachytherapyand simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone, Brachytherapy, vol.11, issue.3, p.224229, 2012. ,
Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate, British Journal of Ophthalmology, vol.94, issue.4, p.460466, 2010. ,
DOI : 10.1136/bjo.2009.162487
Iodine brachytherpy as an alternative to enucleation for large uveal melanomas, p.22232234, 2003. ,
Longterm risk of local failure afterprotontherapyforchoroidal/ciliarybodymelanoma, TransAmophtalmolSoc, vol.100, p.4348, 2002. ,
Radiationcomplicationsandtumorcontrolafterplaque radiotherapy of choroidal melanoma with macular involvement, American J Ophthalmol, vol.579589, p.127, 1999. ,
Riskfactorsforradiationmaculopathyafterophthalmic plaqueradiationforchoroidalmelanoma, AmJOphtalmol, vol.149, issue.4, p.608615, 2010. ,
Alternative dose for choroidal melanoma treated with an iodine125 radioactive plaque: A singleinstitution retrospectivestudy, p.844848, 2010. ,
Radiationcomplicationsandtumorcontrolafter125Iplaquebrachytherpy forocularmelanoma.IntJRadiatOncolBiolPhys2005;63:101108 cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative OcularMelanomaStudy:COMSreportno27, Ophtalmology, vol.114, issue.7, p.13631371, 2007. ,
Vascular Endothelial Growth Factor A in Eyes With Uveal Melanoma, Archives of Ophthalmology, vol.124, issue.10, p.14281434, 2006. ,
DOI : 10.1001/archopht.124.10.1428
Iris and anterior chamber angle neovascularisationafteriodine125brachytherapyforuvealmelanoma, Ophtalmology, vol.112, p.505510, 2005. ,
Tumorangiogenesis:therapeuticimplications, NewEnglandJournalofMedicine, vol.285, p.11821186, 1971. ,
OldfieldEH:Furthercharacterizationofmalignantglioma?derived vascularpermeabilityfactor, Jneurosurg, vol.69, p.254262, 1988. ,
Circulating VEGF Levels in the Serum of Gastric Cancer Patients, Annals of Surgery, vol.236, issue.1, p.3742, 2002. ,
DOI : 10.1097/00000658-200207000-00007
BerberogluU:correlationofvascularendothelialgrowth factor ( VEGF) and CEA with clinicopathological variables in colorectal cancer patients, Neoplasma, vol.51, p.293299, 2004. ,
Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma, British Journal of Surgery, vol.91, issue.2, p.242247, 2004. ,
DOI : 10.1002/bjs.4398
A phase I/II dose ?escalation trial of bevacizumab in previouslytreatedmetastaticbreastcancer, p.117124, 2003. ,
Arandomizedphase2trialofbevacizumabwithorwithoutdailylow dose interferon alpha2bin metastatic malignant melanoma, Ann Surg Oncol, vol.14, 2007. ,
PhaseIIItrialofbevacizumabincombinationwithgemcitabine anderlotinibinpatientswithmetastaticpancreaticcancer, p.22312237, 2009. ,
Antivascular endothelial growth factor bevacizumab (avastin ) for radiationretinopathy, ArchOphtalmol, vol.125, p.751756, 2007. ,
Thevascularendothelialgrowthfactorfamily:identificationofa fourthmolecularspiciesandcharacterizationofalternativesplicingofRNA, MolEndocrinol, vol.5, p.18061814, 1991. ,
KeshetE:Vascularendothelialgrowthfactorinducedbyhypoxia maymediatehypoxia?initiatedangiogenesis, p.843845, 1992. ,
The vascular endothelial growth factor ( VEGF ) / VEGF receptor systemanditsroleunderphysiologicalandpathologicalconditions, ClinSci(Lond), vol.109, p.227241, 2005. ,
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, Science, vol.307, issue.5706, p.5862, 2005. ,
DOI : 10.1126/science.1104819
VEGF and angiopoietin signalling in tumor angiogenesis and metastasis, TrendsinMolecularMedicine, vol.17, issue.7, p.347362, 2011. ,
Antiangiogenic therapy in uveal melanoma, Dev Ophtalmol . Basel, Karger, vol.49, p.117136, 2012. ,
TeeAR:Hypoxia?inductiblefactor1alphaisregulatedbythemammaliantargetof rapamycin(mTOR)signalingmotif, JBiolChem, vol.282, p.2053420543, 2007. ,
Bortezomib mediates antiangiogenesis in multiple myeloma via direct andindirecteffectsonendothelialcells, CancerRes, vol.66, pp.184-191, 2006. ,
Effects of thalidomide and related metabolites in a mousecornealmodelofneovascularization, ExpeyeRes, vol.64, p.971978, 1997. ,
Vascularendothelialgrowthfactorsandangiogenesisineye disease, ProgRetinEyeRes, vol.22, p.129, 2003. ,
Ranibizumabinmyopicchoroidalneovascularization: the12monthresultsfromtheREPAIRstudy, Ophtalmology, vol.120, issue.9, p.19441945, 2013. ,
Treatment of Radiation Maculopathy With Intravitreal Injection of Bevacizumab (Avastin), Retina, vol.28, issue.7, p.964968, 2008. ,
DOI : 10.1097/IAE.0b013e3181706302
Intravitreous Ranibizumab (Lucentis) for Radiation Maculopathy, Archives of Ophthalmology, vol.128, issue.2, p.249252, 2010. ,
DOI : 10.1001/archophthalmol.2009.376
Rapid improvement of radiation ?induced neovascular glaucoma and exudative retinal detachment after a single intravitrealranibizumabinjection, ClinExperimentOphtalmol, vol.35, p.878880, 2007. ,
Intracameral bevacizumab in the treatmentofneovascularglaucomaandexudativeretinaldetachmentafterbrachytherapy inchoroidalmelanoma, CanJOphtalmol, vol.44, p.106107, 2009. ,
Longtermsurvivalofuvealmelanomapatientsaftersurgery forlivermetastases, BritishJournalofOphtalmology, vol.93, issue.8, p.10421046, 2009. ,
Liver function tests in metastatic uveal melanoma, American Journal of Ophthalmology, vol.137, issue.2, p.236243, 2004. ,
DOI : 10.1016/j.ajo.2003.08.045
identification of circulating malignantcellsanditscorrelationwithprognosticfactorsandtreatmentinuvealmelanoma, Aprospectivelongitudinalstudy.Eye(Lond), vol.21, issue.6, p.752759, 2007. ,
Uveal melanoma dormancy, Melanoma Research, vol.22, issue.5, p.334340, 2012. ,
DOI : 10.1097/CMR.0b013e328357bea8
Metastatic uveal melanoma: diagnosis end treatment. A literaturereview, BullSocBelgeOphtalmol, vol.286, p.5963, 2002. ,
Assessment of metastatic disease status at deathin435patientswithlargechoroidalmelanomaintheCollaborativeOcularMelanoma Study(COMS):COMSreportno15, ArchOphtalmol, vol.119, issue.5, p.670676, 2001. ,
metastatic uveal melanoma : biology and emerging treatments, cancer J, vol.18, issue.2, p.148152, 2012. ,
TheinsulinlikegrowthfactorIreceptor:akeytotumorgrowth?, CancerRes, vol.55, p.249252, 1995. ,
Prognostic Factors in Choroidal and Ciliary Body Melanomas, Archives of Ophthalmology, vol.95, issue.1, p.6369, 1977. ,
DOI : 10.1001/archopht.1977.04450010065005
Adjuvantinterferontherapyforpatientswithuvealmelanomaat highriskofmetastasis, Ophtalmology, vol.116, issue.11, p.22062212, 2009. ,
Preclinical examination of first and second generation photosensitizers used in photodynamictherapy, Photochemphotobiol, vol.54, issue.6, p.10931107, 1991. ,
Therapeutic strategies for hepatic metastasis of colorectal cancer: overview, Journal of Hepato-Biliary-Pancreatic Sciences, vol.24, issue.5, p.523527, 2012. ,
DOI : 10.1007/s00534-012-0524-8
arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma : a randomizedcontrolledtrial, Lancet, vol.359, issue.9319, p.17341739, 2002. ,
Immunoembolizationofmalignantlivertumors, includinguvealmelanoma,usinggranulocytemacrophagecolony?stimulatingfactor, JClin oncol, vol.26, issue.33, p.54365442, 2008. ,
Metastaticocularandcutaneousmelanoma:acomparison ofpatientcharacteristicsandprognosis, ArchOphtalmol, vol.114, issue.1, p.107108, 1996. ,
Metastatic uveal melanoma, Melanoma Research, vol.21, issue.3, p.217222, 2011. ,
DOI : 10.1097/CMR.0b013e3283457726
Highthroughputmassspectrometrybasedmutation profilingofprimaryuvealmelanoma, InvestOphtalmolVisSci, vol.53, issue.11, p.69916996, 2012. ,
Tumor , node , metastasis classification of malignant ciliary body and choroidalmelanoma, p.11351144, 2005. ,
Longterm results after proton irradiation of uveal melanomas, Graefes Arch ClinExpOphthalmolol, vol.35, p.265267, 1997. ,
Eyeretention after proton beam radiotherapy for uveal melanoma, Int J Radiation Oncology Biol Phys, vol.55, p.86780, 2003. ,
Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparisonoflocalrecurrencerates], JFrOphtalmol, vol.26, issue.3, p.269276, 2003. ,
Resultsoftreatinguveal melanomawithprotonbeamradiation:10yearfollowup], JFrOphtalmol, vol.28, issue.8, p.833, 2005. ,
Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanomaAfiveyearstudyofslottedeyeplaqueradiationtherapyfor choroidalmelanoma:near,touching,orsurroundingtheopticnerve, Ophthalmology. AoûOphthalmology, vol.106119, issue.82, pp.1579-1587, 1999. ,
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma .Investigative Ophtalmology and visual science, p.28352842, 2010. ,
Combination of bevacizumab and irradiation on uveal melanoma:aninvitroandinvivopreclinicalstudy, InvestNewDrugs, vol.31, p.5965, 2013. ,
The proliferation of malignant melanoma cells could be inhibited by ranibizumabviaantagonizingVEGFthroughVEGFR1 104BagriAetal.Effectsofanti?VEGFtreatmentdurationontumorgrowth,tumorregrowth, andtreatmentefficacy 105DeBockKetal.Antiangiogenictherapy,hypoxia,andmetastasis:riskyliaisons,ornot? NatRevClinOncol, MolecularVision.ClinCancerRes, vol.20168, p.64966038873900393404, 2010. ,
Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials, Journal of Clinical Oncology, vol.29, issue.1, p.83, 2011. ,
DOI : 10.1200/JCO.2010.30.2794
Antiangiogenesis and metastasis : a tumour and stromal cell alliance 108Schomber,Tetal.Differentialeffectsofthevascularendothelialgrowthfactorreceptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis, JInternMed. Mol CancerTher, vol.2738, p.1281375563, 2009. ,
Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan, Journal of Clinical Oncology, vol.26, issue.2, pp.271-278, 2008. ,
DOI : 10.1200/JCO.2007.13.3652
Hypoxia Generates a More Invasive Phenotype of Tumour Cells: An In Vivo Experimental Setup Based on the Chorioallantoic Membrane, Pathology & Oncology Research, vol.428, issue.3, p.417422, 2009. ,
DOI : 10.1007/s12253-008-9140-y
Drug resistance by evasion of antiangiogenic targeting of VEGF signalling in late ?stage pancreatic islet tumors, Cancer, vol.8, p.299309, 2005. ,
Patterns of disease progression in metastaticrenalcellcarcinomapatientstreatedwithantivascularagentsandinterferon: impact of therapy on recurrence patterns and outcome measures, Cancer.Oncogene, vol.11531, pp.18591866-114, 2009. ,
The impact of intravitreal bevacizumab therapy on choroidalmelanomaBevacizumabandintraoculartumors:anintriguingparadoxBimodalmortalitydynamicsforuvealmelanoma:acue formetastasisdevelopmenttraits?, AmJOphtalmol.MolecularvisionBMCCancer.BenjaminLE:Tumorigenesisandtheangiogenicswitch.IntjRadiatOncolBiolPhys, vol.1511814339, issue.5, pp.323328-116, 1997. ,
Intravitrealdexamethasone0.7mgimplantfor radiationmacularedemaafterprotonbeamtherapyforchoroidalmelanoma, 17841790 9. SERMENTD'HIPPOCRATE 9..SERMENTD'HIPPOCRATE EnprésencedesMaîtresdecettefaculté, Demescherscondisciplesetdevantl'effigied'Hippocrate, Jeprometsetjejured'êtrefidèleauxloisdel'honneur Etdelaprobitédansl'exercicedelamédecine, 2013. ,
Admisàl'intérieurdesmaisons, Mesyeuxneverrontpascequ'ils'ypasse, Malanguetairalessecretsquimeserontconfiés Etmonétatneservirapasàcorromprelesmoeursniàfavoriserlecrime ,